Laboratory News and Research

RSS

Scientists explain how engineered anthrax toxin proteins could help eliminate cancerous tumors

Scientists from the National Institute of Allergy and Infectious Diseases, the National Institute of Dental and Craniofacial Research, and the National Heart, Lung and Blood Institute all parts of the National Institutes of Health, describe how combining engineered anthrax toxin proteins and existing chemotherapy drugs could potentially yield a therapy to reduce or eliminate cancerous tumors.

28 Jun 2016

Researchers test new drug with potential to reverse or slow progression of asthma

A new drug with the potential to reverse or slow the development of asthma is being tested by researchers at The University of Queensland.

28 Jun 2016

ISU researchers design nanomachine capable of detecting mock version of Ebola virus

Imagine you want to build an intricate work of architecture, like a castle. Now imagine that, once all its individual components are brought together, the castle builds itself automatically. Finally, imagine this castle is so small that it's measured on the same scale as DNA, viruses and small molecules.

28 Jun 2016

New research shows Fukushima radioactive fallout on Tokyo enclosed in glassy microparticles

New research shows that most of the radioactive fallout which landed on downtown Tokyo a few days after the Fukushima accident was concentrated and deposited in non-soluble glass microparticles, as a type of 'glassy soot'.

27 Jun 2016

Anthrax capsule vaccine offers protection from deadly anthrax infection in monkeys

Vaccination with the anthrax capsule--a naturally occurring component of the bacterium that causes the disease--completely protected monkeys from lethal anthrax infection, according to a study published online this week in the journal VACCINE.

27 Jun 2016

Federal government continues to ban valid scientific research on medicinal use of Cannabis sativa

The use of medical marijuana for millions of patients suffering from a wide range of health conditions and the subsequent therapeutic benefits has long been documented.

25 Jun 2016

Oncogene signatures could help design new drug treatments for breast cancer

Drug treatments for breast cancer patients might soon be designed based on the unique genetic autograph of their tumor.

25 Jun 2016

Health-promoting bacteria may protect women from breast cancer

Bacteria that have the potential to abet breast cancer are present in the breasts of cancer patients, while beneficial bacteria are more abundant in healthy breasts, where they may actually be protecting women from cancer, according to Gregor Reid, PhD, and his collaborators.

25 Jun 2016

Study examines how gender and FH may affect alcohol use in adolescents

Gender and a family history of alcoholism (FH) are two genetically determined factors known to affect someone's risk for developing alcohol-use disorders (AUDs). Adolescence is also a critical period for the development of AUDs; drinking habits can be unstable and environmental factors such as peer pressure may be substantial.

25 Jun 2016

Researchers tune into previously unknown cross talk between estrogen and progesterone receptors

One of the first clues pathologists look for in tissue from a newly diagnosed breast cancer patient is the estrogen receptor, a nuclear protein that converts hormonal messages in the bloodstream into instructions for the cell about how to behave

24 Jun 2016

3D-printed model guides doctors to safely remove tumor from kidney

Doctors and scientists at Intermountain Medical Center in Salt Lake City printed and used a 3D kidney to help save a patient's organ during a complicated tumor-removal procedural.

24 Jun 2016

Siemens Healthineers' new CT and MRI technologies to aid research across various common clinical pathways

The Transforming Outcomes and Health Economics Through Imaging (TOHETI) programme is looking to change the way medical imaging works by undertaking a range of pioneering research.

24 Jun 2016

New Bruker In-Vivo Xtreme II system accelerates preclinical infectious disease research at University of Lausanne

Bruker’s recently introduced preclinical in vivo imaging system – In-Vivo Xtreme II™– is accelerating the preclinical research into infectious diseases being undertaken at the Institute of Microbiology at the University of Lausanne, Switzerland. Infectious diseases are the second leading cause of death worldwide.

From Bruker BioSpin Group 24 Jun 2016

CD Laboratory at MedUni Vienna explores new therapeutic approaches to enhance peritoneal dialysis

One of the main functions of the kidneys is to filter metabolic products out of the blood. If the kidneys are no longer able to do this, the blood has to be artificially purified and drained of excess fluid.

24 Jun 2016

Scientists isolate antibodies capable of neutralizing dengue and Zika virus

Scientists from the Institut Pasteur and the CNRS, in collaboration with Imperial College London and the University of Vienna, Austria, have identified antibodies that can efficiently neutralize both the dengue virus and the Zika virus.

24 Jun 2016

Broccoli sprout extract may help prevent cancer recurrence in head and neck cancer survivors

Potent doses of broccoli sprout extract activate a "detoxification" gene and may help prevent cancer recurrence in survivors of head and neck cancer, according to a trial by the University of Pittsburgh Cancer Institute, partner with UPMC CancerCenter, confirming preliminary results presented last year at the American Association for Cancer Research Annual Meeting.

24 Jun 2016

Scientists discover how faulty genetic instructions contribute to development of AML

Scientists have previously identified a series of genetic errors that commonly occur inside cancerous blood cells, but it hasn't been clear exactly how those genetic malfunctions create immature blood cells that overpopulate, crowd out healthy cells and spread in patients with acute myeloid leukemia or AML.

24 Jun 2016

Laboratory News and Research

Scientists explain how engineered anthrax toxin proteins could help eliminate cancerous tumors

Researchers test new drug with potential to reverse or slow progression of asthma

ISU researchers design nanomachine capable of detecting mock version of Ebola virus

New research shows Fukushima radioactive fallout on Tokyo enclosed in glassy microparticles

Anthrax capsule vaccine offers protection from deadly anthrax infection in monkeys

Federal government continues to ban valid scientific research on medicinal use of Cannabis sativa

Oncogene signatures could help design new drug treatments for breast cancer

Health-promoting bacteria may protect women from breast cancer

Study examines how gender and FH may affect alcohol use in adolescents

Researchers tune into previously unknown cross talk between estrogen and progesterone receptors

3D-printed model guides doctors to safely remove tumor from kidney

Siemens Healthineers' new CT and MRI technologies to aid research across various common clinical pathways

New Bruker In-Vivo Xtreme II system accelerates preclinical infectious disease research at University of Lausanne

CD Laboratory at MedUni Vienna explores new therapeutic approaches to enhance peritoneal dialysis

Scientists isolate antibodies capable of neutralizing dengue and Zika virus

Broccoli sprout extract may help prevent cancer recurrence in head and neck cancer survivors

Scientists discover how faulty genetic instructions contribute to development of AML

Study reveals surprising diversity in single neuronal transcriptomes of the brain

Stony Brook researcher receives grant to evaluate daily activity levels, heart rate patterns of CFS patients

Pre-existing dengue antibodies can intensify Zika virus infection

Pittcon 2024 - Advancing Science on the West Coast eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics